Daftar Pustaka

Adiga, U.S. and Adiga, M.N.S., 2009. Total Antioxidant Activity in Normal
Pregnancy. Online J Health Allied Scs; 8(2):8.

Agrawal, D., Shajil, E.M., Marfatia, Y.S., Rasheedunnisa, B. 2004. Study on The
Antioxidant Status of Vitiligo Patients of Different Age Groups in Baroda.
Pigment Cell Res; 17: 289-94.

Alessio, H.M. 2006. Oxidative Stress Across The Exercise Continuum. In:
Alessio, H.M., Hagerman, A.E., editors. Oxidative Stress, Exercise, and
Aging. USA: Imperial College Press. p. 59-84.

Alexandrova, M.L. and Bochev, P.G. Phagocyte Mitochondrial Superoxide

Production and Erythrocyte Cu-Zn Superoxide Dismutase Activity
Decline in Very Old Age. J Biomed Clin Res; 3(1): 27-32.

Alghamdi, K.M., Kumar, A., Taieb, A., Ezzedine, K. 2012. Assessment Methods
for The Evaluation of Vitiligo. JEADV; 26: 1463-71.

Alikhan, A., Felsten L.M., Daly, M., Petronic-Rosic, V. 2011. Vitiligo: A

Comprehensive Overview. J Am Acad Dermatol; 65(3): 473-91.

Al-Wasiti, E., Al- Tammimy, S.A., Al-Rubayee, W.T. 2010. The Role of
Oxidative Stress in Vitiligo and Alopecia Areata. Iraqi J Comm Med; 4:
287-91.

Alzolibani, A.A., Robaee, A.A., Zedan, K., 2011. Genetic Epidemiology and
Heritability of Vitiligo. In: Park, K.K., Ed. Vitiligo Management and
Therapy. Shanghai: InTech. p. 17-30.

Amit, K. and Priyadarsini, K.I. 2011. Free Radicals, Oxidative Stress and
Importance of Antioxidants in Human Health. J Med Allied Sci; 1(2): 53-
60.

Arican, O., Kurutas, E.B. 2008. Oxidative Stres in the Blood of Patients with
Active Localized Vitiligo. Acta Dermatoven APA; 17(1): 12-6.

Atukeren, P. and Yigitoglu, M.R. 2013.The Stance of Antioxidants in Brain

Tumors. In: Lichtor, T., editor. Clinical Management and Evolving Novel
Therapeutic Strategies for Patients with Brain Tumors. Croatia: Intech. p.
523-51.

Benzekri, L., dkk. 2013. Vitiligo Potential Repigmentation Index: a Simple

Clinical Score that Might Predict the Ability of Vitiligo Lesions to
Repigment Under Therapy. Br J Dermatol; 168:1143–6.

79
 80

Bhor U, Pande S. 2006. Scoring System in Dermatology. Indian J Dermatol

Venereol Leprol; 72: 315-21.

Birlea, S.A., Spritz, R.A., Norris, D.A. 2012. In: Wolff, K., Goldsmith, L.A.,
Katz, S.I., Gilchrest, B.A., Paller, A.S., Leffell, D.J., Eds. Fitzpatrick ’s
Dermatology In General Medicine. 8th Ed. New York: McGraw Hill.
p.792-803.

Briganti, S. and Picardo, M. 2002. Antioxidant Activity, Lipid Peroxidation, and

Skin Diseases: What’s New. J Eur Acad Dermatol Venereol; 17: 663-9.

Chakraborty, D.P., Roy, S., Chakraborty, A.K. 1996. Vitiligo, Psoralen, and
Melanogenesis: Some Observations and Understanding. Pigment Cell Res;
9:107-16.

Dammak, I., Boudaya, S., Abdallah, F.B., Turki, H., Attia, H., Hentati, B. 2009.
Antioxidant Enzymes and Lipid Peroxidation at Tissue Level in Patients
with Stable and Active Vitiligo. Int J Dermatol; 48: 476-80.

Dammak, I., Boudaya, S., Riadh, B.M., Amel, E.G., Slaheddine, M., Hamida, T.,
Hamadi, A., Basma, H. 2006. A Comparative Study of Oxidant-
Antioxidant Status in Stable dan Active Vitiligo Patients. Arch Dermatol
Res; 298: 147-52.

Daneshpazhooh, M., Mostofizadeh, G.M., Behjati, J., Akhyani, M., Robati, R.M.
2006. Antithyroid Peroxidase Antibody and Vitiligo: a Controlled Study.
BMC Dermatol; 6: 3-6.

Das, S.K., Majumder, P.P., Chakraborty, R., Majumder, T.K., Haldar, B. 1985.
Studies on Vitiligo. I. Epidemiological Profile in Calcutta, India. Genet
Epidemiol; 2: 71-8.

Dell’Anna, M.L., Maresca V., Briganti, S. 2001. Mitochondrial Impairment in

Peripheral Blood Mononuclear Cells during Active Phase of Vitiligo. J
Invest Dermatol; 117: 908-13.

Denat, L., Kadekaro, A.L., Marrot, L., Leachman, S.A., Abdel-Malek, A.A. 2014.
Melanocytes as Instigators and Victims of Oxidative Stress. JID: 1-7.

Devasagayam, T.P.A., Tilak, J.C.,Boloo, K.K., Sane, K.S., Ghaskadbi, S.S., Lele,
L.L.2004. Free Radicals and Antioxidanta in Human Health: Current
Status and Future Prospects. JAPI; 52: 794-804.

Doghim, N.N., Hasan, A.M., El Ashmawy A.A., Gheida, S.F. 2011. Topical
Antioxidant and Narrowband versus Topical Combination of Calcipotriol
plus Betamethathone Dipropionate and Narrowband in the Treatment of
Vitiligo. Life Sci J; 8(4): 186-97.
 81

Dogra, S., Parsad, D., Handa, S., Kanwar, A.J. 2005. Late Onset Vitiligo: a Study
of 182 Patients. Int J Dermatol; 44: 193-6.

Esfandiarpour, I., Farajzadeh, S. 2012. Clinical Characteristics of Late Onset

Vitiligo in Iranian Population. Dermatologica Sinica; 30: 43-6.

Ezzedine, K., Lim, H.W., Suzuki, T., Katayama, I., Hamzavi, I., Lan, C.C.E.,
Goh, B.K.,Anbar, T., Silva de Castro, C., Lee, A.Y., Parsad, D., Van Geel,
N., Le Poole, I.C., Oiso, N., Benzekri, L., Spritz, R., Gauthier, Y., Hann,
S.K., Picardo, M., Taieb, A. 2012. Revised Classification/ Nomenclature
of Vitiligo and Related Issues: The Vitiligo Global Issues Consensus
Conference. Pigment Cell Melanoma Res; 25: E1-13.

Fang, Y.U., Yang, V.S., Wu, G. 2002. Free Radicals, Antioxidants, and Nutrition.
Nutrition; 18: 872-9.

Feily, A. 2014. Vitiligo Extent Tensity Index (VETI) Score: A New Definition,
Assessment and Treatment Evaluation Criteria in Vitiligo. Dermatol Pract
Concept; 4(4):18.

Fuchs, J., Herrling, T., Groth, N. 2001. Detection of Free Radicals in Skin: A
Review of The Literature and New Developments. In: Thiele, J., Elsner,
P., editors. Oxidant and Antioxidants in Cutaneous Biology. Basel:
Karger. p. 1-17.

Galadari, I., Bener, A., Hadi, S., Lestringant, G.G. 1997. Clinical and
Immunological Studies in Vitiligo in The United Arab Emirats. Allerg
Immunol; 29: 297-9.

Gawkrodger, D.J., Ormerod, A.D., Shaw, L., Mauri-Sole, M.E., Watts, M.J.,
Anstey, A.V., Ingham, J., Young, K. 2008. Guideline for Diagnosis and
Management of Vitiligo. BJD; 159: 1051-76.

Habib, A., Raza, N. 2012. Clinical Pattern of Vitiligo. J col physic surg; 22(1):
61-2.

Hamzavi, I., Jain, H., Mclean, D., Shapiro, J., Zeng, H., Lui, H. 2004. Parametric
Modelling of Narrowband UV-B Phototherapy for Vitiligo Using A Novel
Qualitative Tool: The Vitiligo Area Scoring Index. Arch Dermatol; 140:
677-83.

Hazneci, E., Karabulut, A.B., Ozturk, C., Batcioglu, K., Dogan, G., Karaca, S.,
Esrefoglu, M. 2004. A Comparative Study of Superoxide Dismutase,
Catalase, and Glutathione Peroxidase Activities and Nitrate Levels in
Vitiligo Patients. Inter J Dermatol; 44: 636-40
 82

Jain, A., Mal, J., Mehndiratta, V., Chander, R., Patra, S.K. 2011. Study of
Oxidative Stress in Vitiligo. Ind J Clin; 26(1): 78-81.

Kadekaro, A.L., Kavanagh, R., Kanto, H. 2005. Α-Melanocortin and Endothelin-1

Active Anti-Apoptotic Pathways and Reduce DNA Damage in Human
Melanocyte. Mol Cancer Res; 10:778-86.

Kawakami, T., Hashimoto, T. 2011. Disease Severity Indexes and Treatment

Evaluation Criteria in Vitiligo. Dermatol Res Prac: 1-3.

Khan, R., Satyam, A., Gupta, S., Sharma, V.K., Sharma, A. 2009. Circulatory
Levels of Antioxidants and Lipid Peroxidation in Indian Patients with
Generalized and Localized Vitiligo. Arch Dermatol Res; 301: 731-7.

Khansari, N., Shakiba, N., Mahmoudi, M. 2009. Chronic Inflammation and

Oxidative Stress as a Major Cause of Age-Related Disease and Cancer.
Recent Pat Inflamm Allergy Drug Discov; 3:73-80.

Khrisnamurthy, P. and Wadhwani, A. 2012. Antioxidant Enzymes and Human

Health. In: El-Missiry, M.A., editor. Antioxidant Enzyme. Croatia: Intech.
p. 3-18.

Koca, R., Armutcu, F., Altinyazar, H.C., Gurel, A. 2004. Oxidant-Antioxidant

Enzymes and Lipid Peroxidation in Generalized Vitiligo. Clin Exper
Dermatol; 29: 406-9.

Kostovic, K., Pastar, K., Pasic, A., Ceovic, R. 2007. Treatment of Vitiligo with
Narrow-Band UVB and Topical Gel Containing Catalase and Superoxide
Dismutase. Acta Dermatovenerol Croat; 15(1): 10-4.

Loven D.P., Oberley L.W. 1985. Free Radicals, Insulin Action and Diabetes. In:
Oberley, L.W., editor. Superoxide Dismutase. Floida: CRC press. p 151-
81.

Lykkesfeldt, J., Viscovich, M., and Poulsen, H.E. 2004. Plasma Malondialdehyde
is Inducing by Smokin: A Study with Balanced Antioxidant Profiles.
British J Nutrition; 92: 203-6.

Madazli, R., Benian, A., Aydin, S., Uzun, H., Tolun, N. 2002. The Plasma and
Placental Levels of Malondialdehyde, Glutathione and Superoxide
Dismutase in Pre-Eclampsia. J Obst and Gynaecol; 22(5): 477-80.

Majid, I. 2010. Vitiligo Management: An Update. BJMP; 3(3): 1-6.

Maresca, V., Roccella, M., Roccella, F., Camera, E., Del Porto, G., Passi, S.,
Grammatico, P., Picardo, M. 1997. Increased Sensitivity to Peroxidative
 83

Agents as a Possible Pathogenic Factor of Melanocyte Damage in Vitiligo.

J Invest Dermatol; 109: 310-3.

Naini, F.F., Shooshtari, A.V., Ebrahimi, B., Molaei, R. 2012. The Effect of
Pseudocatalase/Superoxide Dismutase in the Treatment of Vitiligo: A Pilot
Study. J Res Pharm Pract; 1(2): 77-80

Nanda, A., Kaur, S., Bhakoo, O.N., Dhall, K. 1989. Survey of Cutaneous Lesion
in India Newborns. Pediatr Dermatol; 6: 39-42.

Njoo, dkk. 1999. Association of the Köbner Phenomenon with Disease Activity
and Therapeutic Responsiveness in Vitiligo Vulgaris. Arch Dermatol;135:
407-13.

Onunu, A.N., Kubeyinje, E.P. 2003. Vitiligo in Nigerian African: a Study of 351
Patients in Benin City, Bigeria. Int J Dermatol; 42: 800-2.

Parsad, D., Dogra, S., Kanwar, A.J. 2003. Quality of Life in Patients with Vitiligo.
Health Qual Life Outcomes. 1: 1-3.

Radakovic-Fijan, S., Furnsinn, F.A.M., Honigsmann, H., Tanew, A. 2001. Oral

Dexamethason Pulse Treatment for Vitiligo. J Am Acad Dermatol; 44:
814-7.

Schallreuter, K.U., Moore, J., Wood, J.M., Beazley, W.D., Gaze, D.C., Tobin,
D.J., Marshall, H.S., Panske, A., Panzig, E., Hibberts, N.A. 1999. In Vivo
and In Vitro Evidance of Hydrogen Peroxide Accumulation in The
Epidermis of Patients with Vitiligo and its Successful Removal by a UV-B
Activated Pseudocatalase. J Invest Dermatol Symp Proc; 4: 91-6.

Schallreuter, K.U., Rubsam, K., Gibbons, N.C., et al. 2008. Methionine Sulfoxide
Reductase A and B are Deactivated by Hydrogen Peroxide (H2O2) in The
Epidermis of Patients with Vitiligo. J Invest Dermatol; 128: 808-15.

Shajil, E.M., Agrawal, D., Vagadia, K., Marfatia, Y.S., Begum, R. 2006. Vitiligo:
Clinical Profiles in Vadodara. Indian J Dermatol Venereol; 51(2): 100-4.

Spencer, J.D., Gibbons, N.C., Rokos, H. 2007. Oxidative Stress via Hydrogen
Peroxide Affects Proopiomelanocortin Peptides Directly in Epidermis of
Patients with Vitiligo. J Invest Dermatol; 127:411-20.

Sravani, P.V., Babu, N.K., Gopal, K.V., Rao, G.R., Rao, A.R., Moorthy, B., Rao,
T.R. 2009. Determination of Oxidative Stress in Vitiligo by Measuring
Superoxide Dismutase and Catalase Levels in Vitiliginous and Non-
Vitiliginous Skin. Indian J Dermatol Venereol Leprol; 75(3): 268-71.
 84

Taieb, A., Alomar, A., Bohm M., Dell’Anna, M.L., De Passe, A., Elefheriadou,
V., Ezzedine, K. 2013. Guidelines for The Management of Vitiligo: The
European Dermatology Forum Consensus. BMJ; 168: 5-19.

Taieb, A., Picardo M. Epidemiology, Definitions, and Classification. 2010. In:

Taieb, A., Picardo M., Eds. Vitiligo. Berlin: Springer. p. 13-24.

Taieb, A., Picardo, M. 2007. The Definition and Assessment of Vitiligo: A

Consensus Report of The Vitiligo European Task Force. Pigment Cell Res;
20: 27-35.

Valko, M., Leibfritz, D., Moncola, J., Cronin, M.T., Mazura, M., Telser, J. 2007.
Free Radicals and Antioxidants in Normal Physiological Functions and
Human Disease. Int J Biochem Cell B; 39: 44-8.

Winarsi, H. 2007. Radikal Bebas dan Antioksidan. In: Winarsi, H, editor.

Antioksidan Alami dan Radikal Bebas. Yogyakarta: Kanisius. p.11-25.

Yaghoobi, R., Omidian, M., Bagherani, N. 2011. Vitiligo: A review of The

Published Work. J dermatol; 38: 419-31.

Yildirim, M., Baysal, V., Inaloz, H.S., Kesici, D., Delibas, N. 2003. The Role of
Oxidant and Antioxidants in Generalized Vitiligo. J Dermatol; 30: 104-8.

Yoshikawa, T. and Naito, Y. 2002. What is Oxidative Stress?. JMAJ; 45(7): 271-
6.

Zhou, Z., Li, C.Y., Li, K. 2009. Decrease Methionine Sulfoxide Reductase A
Expression Renders Melanocytes More Sensitive to Oxidative Stress: A
Possible Cause for Melanocyte Loss in Vitiligo. Br J Dermatol; 161: 504-
9.